| Price | 6.75p on 21-11-2025 at 19:35:04 |
|---|---|
| Change | 0.00p 0% |
| Buy | 7.00p |
| Sell | 6.50p |
| Last Trade: | Buy 100.00 at 7.00p |
| Day's Volume: | 615,414 |
| Last Close: | 6.75p |
| Open: | 6.75p |
| ISIN: | GB00BYV81293 |
| Day's Range | 6.75p - 6.75p |
| 52wk Range: | 2.20p - 9.00p |
| Market Capitalisation: | £71.67m |
| VWAP: | 6.552581p |
| Shares in Issue: | 1.06b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 100 | 7.00p | SI Trade |
16:32:08 - 21-Nov-25 |
| Sell* | 23,892 | 6.50p | SI Trade |
16:32:08 - 21-Nov-25 |
| Sell* | 50,000 | 6.52p | Ordinary |
15:27:20 - 21-Nov-25 |
| Sell* | 19,363 | 6.675p | Ordinary |
15:26:10 - 21-Nov-25 |
| Sell* | 1,783 | 6.51p | Ordinary |
15:22:34 - 21-Nov-25 |
| Sell* | 25 | 6.50p | Ordinary |
14:42:59 - 21-Nov-25 |
| Sell* | 18,405 | 6.52p | Ordinary |
14:10:26 - 21-Nov-25 |
| Sell* | 100 | 6.50p | SI Trade |
13:56:10 - 21-Nov-25 |
| Sell* | 134,881 | 6.52p | Ordinary |
13:28:43 - 21-Nov-25 |
| Sell* | 10,000 | 6.675p | Ordinary |
12:58:06 - 21-Nov-25 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 14th Nov 2025 7:03 am | RNS | Initiation of a Phase II Clinical Trial in Japan |
| 11th Nov 2025 7:00 am | RNS | ACCRUFeR Pediatric PK Results to be Presented |
| 7th Nov 2025 7:03 am | RNS | ACCRUFeR receives Authorisation by Korean Ministry |
| 23rd Oct 2025 7:00 am | RNS | Q3 2025 Trading Update |
| 14th Oct 2025 3:01 pm | RNS | Grant of Share Options to Chief Executive Officer |
| 1st Oct 2025 8:00 am | RNS | Total Voting Rights |
| 1st Oct 2025 7:02 am | RNS | Positive efficacy and tolerance in pediatric trial |
| 15th Sep 2025 7:00 am | RNS | £1.5 million placing supporting growth of ACCRUFeR |
| 4th Sep 2025 7:03 am | RNS | ACCRUFeR® assigned Priority Review in US by FDA |
| 3rd Sep 2025 2:17 pm | RNS | Interim results for the six months ended 30 Jun 25 |
